Epidemiologic evidence for a new class of compounds associated with toxic oil syndrome

Epidemiology

Volumn 10, Issue 2, 1999, Pages 130-134

  Posada De La Paz, Manuel ^a   Philen, Rossanne M ^b   Schurz, Helen ^b   Robert Jr , H Hill ^b   Giménez Ribota, Olga ^a   Gómez De La Camara, Agustín ^a   Kilbourne, Edwin M ^b   Abaitua, Ignacio ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

1,2 di oleyl ester of 3 (N phenylamino) 1,2 propanediol; Rapeseed oil; Toxic oil syndrome

Indexed keywords

ANILIDE; ANILINE; FATTY ACID ESTER; PROPANEDIOL DERIVATIVE; RAPESEED OIL;

ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DENATURATION; EPIDEMIC; MASS SPECTROMETRY; PRIORITY JOURNAL; RISK FACTOR; TOXIC OIL SYNDROME;

EID: 0000662650     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199903000-00008     Document Type: Article

References (18)

1. Philen RM, Posada M. Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization Meeting Report, Seminars in Arthritis and Rheumatism 1993;23:104-124.
2. Grandjean P, Tarkowski S, eds. Toxic oil syndrome: mass food poisoning in Spain. In: Report of a WHO meeting: Madrid 21-25 March 1983. Copenhagen: World Health Organization Regional Office for Europe, 1984;22:3-16.
3. Abaitua Borda I, Posada de la Paz M. Clinical findings. In: World Health Organization, ed. Toxic oil syndrome: current knowledge and future perspectives. Copenhagen: World Health Organization Regional Publications, European Series, No. 42, 1991:28.
4. Tabuenca JM. Toxic allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 1981;2:567-568.
5. Casado Flores J, Casquero J, Colomar P, García M, García F, Morales M, Sánchez A, Tabuenca Oliver JM. Síndrome tóxico por consumo de aceite adulterado: una encuesta alimentaria esclarecedora. (Spanish) Pediàtrika 1982;2:17-20.
6. Posada de la Paz M, Philen RM, Abaitua Borda I, Bernert JT Jr, Bada Gancedo JC, DuClos PJ, Kilbourne EM. Manufacturing processes at two French rapeseed oil companies: possible relationships to toxic oil syndrome in Spain. Food Chem Toxicol 1991;29:797-803-
7. Posada M, Philen RM, Abaitua I, Sicilia J, Gomez A, Kilbourne E. Toxic oil syndrome: a study of oil composition by container type - evidence for a point source epidemic. Food Chem Toxicol 1996;34:251-257.
8. Kilbourne EM, Bernert JT Jr, Posada de la Paz M, Hill RH Jr, Abaitua Borda I, Kilbourne BW, Zack MM, Toxicoepidemiologic Study Group. Chemical correlates of pathogenicity of oils related to the toxic-oil syndrome in Spain. Am J Epidemiol 1988;127:1210-1227.
9. Posada M, Philen RM, Abaitua I. A further study of factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. Epidemiology 1994;5:404-409.
10. Bernert JT Jr, Kilbourne EM, Akins JR, Posada de la Paz M, Meredith NK, Abaitua Borda I, Wages S. Compositional analysis of oil samples implicated in the Spanish toxic oil syndrome. J Food Sci 1987;52:1562-1569.
11. Vázquez Roncero A, Maestro Durán R, Ruiz Gutiérrez V. New aniline derivatives in toxic oil syndrome: toxicity in mice of 3-phenylamino-1,2-propanediol and its fatty acid mono-and diesters. Grasas Aceites 1984;35: 330-331.
12. Hill RH, Schurz H, Posada M, Abaitua I, Philen RM, Kilbourne EM, Head SL, Bailey SL, Driskell WJ, Barr JR, Needham LL. Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(n-phenylamino)-1,2-propanediol. Arch Environ Contam Toxicol 1995;28:259-264.
13. Diamond GA. Limited assurances. Am J Cardiol 1989;63:99-100.
14. Koopman PAR. Confidence intervals for the ratio of two binomial proportions. Biometrics 1984;40:513-517.
15. Abraira V, Zaplana J. PRESTA: Un paquete de procesamientos estadísticos. Proceedings of the Iberoamerican Conference on Bioengineering. Gijón, Spain. 1984;100.
16. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-843.
17. Carthew P, Edwards RE, Dorman BM, Verschoyle RD. A comparison of the acute pathology induced by 3-phenylamino-1,2-propanediol (PAP) and its mono-oleoyl ester in rodents with the toxic oil syndrome in man. Hum Exp Toxicol 1995;14:217-220.
18. Heiskanen K, Savolainen KM. Effects of 3-phenylamino-1,2-propanediol and its mono-and dioleylesters on the production of reactive oxygen metabolites in human polymorphonuclear leukocytes. Toxicol Lett 1997;91: 39-45.